Latest News & Features
Careers
The new hire brings over 20 years of experience in patent prosecution and litigation involving pharmaceuticals, molecular biology and medical technologies. 3 June 2025
Americas
The firm’s new practice unites Faber’s transactional and licensing abilities with Crowell’s regulatory and litigation services, bringing together 50 professionals and expanding into Boston. 3 June 2025
Americas
The seasoned patent litigators join from Mayer Brown, bringing decades of high-stakes experience in pharma and biotech patent disputes, including work on Hatch-Waxman and biosimilar litigation. 2 June 2025
Americas
Novo Nordisk faces resistance from Connecticut clinic in Ozempic and Wegovy dispute | LIVation admits to referencing Novo Nordisk products in past marketing but it has since been removed | Clinic claims its compounded semaglutide use was lawful and clear to patients. 29 May 2025
Americas
Shilpa Medicare failed to prove invalidity of patent covering Lenvima | Eisai says ruling keeps India-based generic maker’s product off the market until 2036. 29 May 2025
Americas
Litigation concerns Novartis’ blockbuster $6bn heart failure drug, which has already expired | Indian generic company hoped to stay proceedings to prepare appeal against unfavourable decision. 27 May 2025
Europe
UPC rejects jurisdictional challenges from Moderna | Court allows two linked infringement cases over mRNA tech to move forward in The Hague | Ruling finds commercial links between Moderna entities enough to justify its jurisdiction over non-UPC territories. 27 May 2025
Careers
New hire is a specialist in pharmaceutical regulatory matters, complex patent disputes, and cross-border transactional support for biotech. 27 May 2025
Europe
With the regime affecting UK exports to the EEA set to continue, Charlotte Peach of Taylor Wessing explores some of the practical implications for businesses. 27 May 2025
Europe
Artificial intelligence is undoubtedly impacting the biotech lifecycle, and presents myriad applications—and risks. Tim Powell, Vishnu Shankar and Ben Rowlatt of Morgan Lewis provide a detailed analysis. 22 May 2025